期刊文献+

优化核酸疫苗对慢性MPTP帕金森病小鼠的免疫作用 被引量:5

Immunological effects of optimized nucleic acid vaccines on chronic MPTP Parkinson's disease mice
下载PDF
导出
摘要 目的评价优化核酸疫苗(pVAX1-IL-4/SYN-B)预防接种对小鼠MPTP损害的免疫保护作用。方法将C57BL/6小鼠随机分为正常对照组、PBS模型组、空质粒模型组、优化核酸疫苗模型组4组,分别在小鼠双后肢胫前肌注射PBS、PBS、空质粒、pVAX1-IL-4/SYN-B各100μl,共3次。末次注射3周后,后3组注射MPTP构建慢性帕金森病小鼠模型,正常对照组注射同体积的PBS。末次给药后观察小鼠行为学变化;免疫组织化学、Western blot检测小鼠黑质部酪氨酸羟化酶(tyrosine hydroxylase,TH)表达情况;RT-PCR检测小鼠黑质TNF-α、IL-1β的mRNA水平。结果与PBS模型组、空质粒模型组相比,优化核酸疫苗模型组小鼠运动症状明显改善;TH丢失减少;TNF-α、IL-1β的mRNA水平表达降低;差异有统计学意义。结论优化核酸疫苗预防接种对小鼠的慢性MPTP损害有一定的神经保护及抗炎作用。 This study aimed to evaluate the protective effects of optimized nucleic acid vaccine(pVAX1-IL-4/SYN-B) on the immune function of model mice of Parkinson’s disease damaged by MPTP.C57BL/6 mice were randomly divided into four groups: normal control group,PBS model group,empty plasmid model group,optimized DNA vaccine model group.Then,the anterior tibial muscles of mouse hind leg were respectively injected with 100 μl of PBS,PBS,empty plasmid,and pVAX1-IL4/SYN-B unilaterally,total for three times at two weeks interval.Three weeks after the last injection,the latter three groups were built the chronic MPTP model by injecting MPTP,while normal control group received the same volume of PBS.After the last administration of MPTP,we observed the behavior changes of mice,evaluated the tyrosine hydroxylase(TH) expression in substantia nigra of mice using immunohistochemistry and western blot methods,and detected the TNF-α and IL1-β mRNA levels in substantia nigra of mice using RT-PCR.We found that the motor symptoms of mice improved significantly,the loss of TH reduced,the TNF-α and IL1-β mRNA levels decreased obviously in optimized DNA vaccine model group which was immunized preventively with pVAX1-IL-4/SYN-B when compared with the PBS model group and/or empty plasmid model group.From these results we can conclude that optimized DNA vaccine has neuroprotective and anti-inflammatory effects in chronic Parkinson’s disease mice induced with MPTP.
出处 《免疫学杂志》 CAS CSCD 北大核心 2012年第11期926-931,共6页 Immunological Journal
基金 重庆市医学科研计划重点项目(2009-1-58) 重庆医科大学附属第一医院医学科学基金项目(YXJJ2009-24) 重庆市医学科研计划项目(2011-2-131)
关键词 帕金森病 优化核酸疫苗 免疫 神经保护 炎症 Parkinson's disease Optimized nucleic acid vaccines Immunization Neuroprotection Inflammation
  • 相关文献

参考文献19

  • 1Gorbatyuk OS, Li S, Sullivan LF, et al. The phosphorylation state of Ser-129 in human alpha-synuclein determines neurodegeneration in a rat model of Parkinson disease [J]. Proc Natl Acad Sci USA, 2008, 105(2): 763-768.
  • 2Mandel S, Grunblatt E, Riederer P, et al. Neuroprotective strategies in Parkinson's disease: an update on progress[J]. CNS Drugs, 2003, 17(10): 729-762.
  • 3Hirsch EC, Hunot S. Neuroinflammation in parkinson's disease: a target for neuroprotection? [J]. Lancet Neurol, 2009, 8(4): 382-397.
  • 4Yokoyama H, Kuroiwa H, Yano R, et al. Targeting reactive oxygen species, reactive nitrogen species and inflammation in MPTP neurotoxicity and Parkinson's disease[J]. Neurol Sci, 2008, 29(5): 293-301.
  • 5Ferrari CC, Tarelli R. Parkinson's disease and systemic inflammation[J]. Parkinsons Dis, 2011: 436813.
  • 6Imamura K, Hishikawa N, Ono K, et al. Cytokine production of activated microglia and decrease in neurotrophic factors of neurons in the hippocampus of Lewy body disease brains[J]. Acta Neuropathol, 2005, 109(2): 141-150.
  • 7Whitton PS. Inflammation as a causative factor in the aetiology of Parkinson's disease[J]. Br J Pharmacol, 2007, 150(8): 963-976.
  • 8何卿玮,王加才,彭国光,王法祥.pVAX1-IL-4/SYN-B融合质粒的构建及表达[J].免疫学杂志,2009,25(5):588-590. 被引量:8
  • 9邵敏贞,张志晓,叶锋平,胡廷松,郑颖,范泉水.金属蛋白酶多抗原表位DNA疫苗诱导免疫应答的研究[J].免疫学杂志,2011,27(5):394-397. 被引量:3
  • 10杨云鹏,杨旭,陈中美,彭国光,周长青,马英,张玉平,王法祥.优化hα-syn核酸疫苗免疫反应效果及安全性的评价[J].免疫学杂志,2011,27(11):941-944. 被引量:2

二级参考文献33

  • 1郑风荣,刘洪展,孙修勤.DNA疫苗的分子佐剂研究进展及其在鱼用疫苗中应用[J].免疫学杂志,2006,22(z1):73-75. 被引量:2
  • 2何卿玮,王加才,彭国光,王法祥.pVAX1-IL-4/SYN-B融合质粒的构建及表达[J].免疫学杂志,2009,25(5):588-590. 被引量:8
  • 3王彤钢.白细胞介素4生物学功能研究进展[J].国外医学(免疫学分册),1994,17(1):13-16. 被引量:28
  • 4张革,邹俊涛,汪华侨,李国营,姚志彬.Aβ_(42)重组多价DNA疫苗的构建及诱导Aβ抗体的产生[J].第四军医大学学报,2005,26(10):865-868. 被引量:7
  • 5Sigurdsson E M.Immunotherapy for conformational diseases[J].Curr Pharm Des,2006;12(20):2569-2585.
  • 6王少君 马宁 彭国光.神经变性构象病的分子机制与治疗策略.第四军医大学学报,2007,28:41-44.
  • 7Dodel R,Hampel H,Deboylu C et al.Human antibodies against amyloidβ peptide:a potential treatment for Alzheimer's disease[J].Ann Neurol,2002;52(2):253-256.
  • 8Orgogozo J M,Gilman S,Dartigues J F et al.Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization[J].Neurology,2003;61(1):46-54.
  • 9Meredith G E,Halliday G M,Toutterdell S.A critical review of the development and importance of proteinaceous aggregates in animal models of Parkinson's disease:new insights into Lewy body formation[J].Parkinsonism Relat Disord,2004;10(4):191-202.
  • 10Masliah E,Rockenstein E,Adame A et al.Effects of alpha-synuclein immunization in a mouse model of Parkinson's disease[J].Neuron,2005;46(6):857-868.

共引文献10

同被引文献80

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部